Infectious Disease

N. L. Beatty et al.

The U.S. Food and Drug Administration has approved Insmed's oral drug for non-cystic fibrosis bronchiectasis. Reuters Health Information

Dr Hope Rugo explores how evolving endocrine strategies and targeted therapies are enhancing outcomes in hormone receptor-positive early-stage breast...

Dr Mark Kris discusses new tools for treating lung cancer emerging from ASCO 2025. Medscape Oncology

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but as more U.S. insurers rest...

A. H. Dratch et al.

T. J. Achatz et al.

C. J. Brackman et al.

Patients with mismatch repair-deficient endometrial cancer have longer overall survival than those with mismatch repair-proficient tumour, a UK study...

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly...